The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is expecting as many as 5000 participants in its 18th Annual European Congress in Milan, Italy.
EUnetHTA is organising two issue panels at the upcoming ISPOR Annual European Congress:
Quality-adjusted life years (QALYs) – Help or hindrance in supporting health care decision making
Moderator: Emelie Maria Heintz, PhD
Panelists: Irina Cleemput, PhD MSc; Mark J. Sculpher, MSc, PhD; Ariel Beresniak, MD, MPH, PhD
Time: Tue, 10 Nov 2015 (13.45-14.45)
Joint assessments in Europe: Can we do it and how?
Moderator: Adrian Griffin, MSc
Panelists: Luciana Ballini, MSc; Wim Goettsch, PhD; Zoe Garrett, MRes
Time: Wed, 11 Nov 2015 (10.00-11.00)
ISPOR Milan as a major European event of the global scientific society on the outcomes research, offers a wide range of relevant to HTA interaction and knowledge sharing opportunities. Just a few programme highlights of relevance to the European HTA cooperation efforts:
First Plenary Session: Strategy in Motion: the current and future lifecycle approach to decision making on health technologies,
Time: Mon, 9 Nov 2015, 9:15-10:45
IP8 (Issue Panel):The cost of no Europe: are there costs and consequences of localized or centralized assessment of relative efficacy?
Moderator: Alastair Kent, OBE;
Panelists: Andrea Rappagliosi, LLM; Carole Longson, PhD; Jacco Keja, PhD
Time: Tue, 10 Nov 2015 (13.45-14.45)
IP11 (Issue Panel): Building the light approach in Central and Eastern European Countries based on HTA recommendations in Western European Countries: More harm than good?
Moderator: Finn Børlum Kristensen, MD, PhD;
Panelists: Katarzyna Kolasa, PhD; Mirjana Huic, MD, PhD; Zoltan Kalo, PhD
Time: Tue, 10 Nov 2015 (15.15-16.15)
We hope to see many of you at ISPOR Milan!
